Digestion of chromatin in apoptotic cell microparticles prevents autoimmunity V Sisirak, B Sally, V d’Agati, W Martinez-Ortiz, ZB Özçakar, J David, ... Cell 166 (1), 88-101, 2016 | 425 | 2016 |
Single-cell RNA-seq of rheumatoid arthritis synovial tissue using low-cost microfluidic instrumentation W Stephenson, LT Donlin, A Butler, C Rozo, B Bracken, A Rashidfarrokhi, ... Nature communications 9 (1), 791, 2018 | 382 | 2018 |
Dnase1l3 deletion causes aberrations in length and end-motif frequencies in plasma DNA L Serpas, RWY Chan, P Jiang, M Ni, K Sun, A Rashidfarrokhi, C Soni, ... Proceedings of the National Academy of Sciences 116 (2), 641-649, 2019 | 176 | 2019 |
Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus J Hartl, L Serpas, Y Wang, A Rashidfarrokhi, OA Perez, B Sally, V Sisirak, ... Journal of Experimental Medicine 218 (5), 2021 | 100 | 2021 |
Kinetics of adult hematopoietic stem cell differentiation in vivo S Upadhaya, CM Sawai, E Papalexi, A Rashidfarrokhi, G Jang, ... Journal of Experimental Medicine 215 (11), 2815-2832, 2018 | 85 | 2018 |
Generation of immunity against pathogens via single-domain antibody–antigen constructs JN Duarte, JJ Cragnolini, LK Swee, AM Bilate, J Bader, JR Ingram, ... The Journal of Immunology 197 (12), 4838-4847, 2016 | 67 | 2016 |
Disruption of Sphingolipid Biosynthesis Blocks Phagocytosis of Candida albicans FG Tafesse, A Rashidfarrokhi, FI Schmidt, E Freinkman, S Dougan, ... PLoS pathogens 11 (10), e1005188, 2015 | 67 | 2015 |
Plasma DNA profile associated with DNASE1L3 gene mutations: clinical observations, relationships to nuclease substrate preference, and in vivo correction RWY Chan, L Serpas, M Ni, S Volpi, LT Hiraki, LS Tam, A Rashidfarrokhi, ... The American Journal of Human Genetics 107 (5), 882-894, 2020 | 53 | 2020 |
KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance AM Zavitsanou, R Pillai, Y Hao, WL Wu, E Bartnicki, T Karakousi, ... Cell reports 42 (11), 2023 | 43 | 2023 |
Sphingomyelin biosynthesis is essential for phagocytic signaling during Mycobacterium tuberculosis host cell entry P Niekamp, G Guzman, HC Leier, A Rashidfarrokhi, V Richina, F Pott, ... Mbio 12 (1), 10.1128/mbio. 03141-20, 2021 | 34 | 2021 |
Quantitative single-cell analysis of signaling pathways activated immediately downstream of histamine receptor subtypes J Van Unen, A Rashidfarrokhi, E Hoogendoorn, M Postma, TWJ Gadella, ... Molecular pharmacology 90 (3), 162-176, 2016 | 24 | 2016 |
Graphene Oxide Nanosheets Modified with Single‐Domain Antibodies for Rapid and Efficient Capture of Cells GY Chen, Z Li, CS Theile, NM Bardhan, PV Kumar, JN Duarte, ... Chemistry–A European Journal 21 (48), 17178-17183, 2015 | 22 | 2015 |
Plasmacytoid dendritic cells are largely dispensable for the pathogenesis of experimental inflammatory bowel disease CM Sawai, L Serpas, AG Neto, G Jang, A Rashidfarrokhi, R Kolbeck, ... Frontiers in immunology 9, 2475, 2018 | 21 | 2018 |
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancer R Pillai, SE LeBoeuf, Y Hao, C New, JLE Blum, A Rashidfarrokhi, ... Science Advances 10 (13), eadm9859, 2024 | 20 | 2024 |
Secreted mammalian DNases protect against systemic bacterial infection by digesting biofilms KA Lacey, L Serpas, S Makita, Y Wang, A Rashidfarrokhi, C Soni, ... Journal of Experimental Medicine 220 (6), e20221086, 2023 | 17 | 2023 |
Visualizing the early stages of phagocytosis A Rashidfarrokhi, V Richina, FG Tafesse Journal of Visualized Experiments: JoVE, 54646, 2017 | 10 | 2017 |
Therapeutic strategies to target tumors with alterations in lkb1 pathway T Papagiannakopoulos, R Pillai, A Rashidfarrokhi, S Koide, SB Koralov US Patent App. 18/388,088, 2024 | | 2024 |
Tumor-intrinsic LKB1-LIF signaling axis establishes a myeloid niche to promote immune evasion and tumor growth A Rashidfarrokhi, R Pillai, Y Hao, WL Wu, B Karadal-Ferrena, ... bioRxiv, 2023.07. 15.549147, 2023 | | 2023 |
LKB1-LIF Signaling Axis Promotes an Immunosuppressive Microenvironment in Lung Adenocarcinoma R Pillai, A Rashidfarrokhi, Y Hao, KK Wong, S Koide, A Tsirigos, ... D98. UPDATE ON THE" OMICS" OF LUNG CANCER: A TRANSLATIONAL SESSION, A6603-A6603, 2023 | | 2023 |
Glutamine antagonist DRP-104 enhances anti-tumor responses in KEAP1 mutant lung cancer R Pillai, S LeBoeuf, A Rashidfarrokhi, SM Huang, T Karakousi, ... Cancer Research 83 (7_Supplement), 4904-4904, 2023 | | 2023 |